Teva announced the launch of Life Effects (url: lifeeffects.teva), a new patient-centric website developed in collaboration with patients for people living with one or more chronic conditions, focusing on the impact that a chronic condition has on a patient’s day-to-day life.
NORTH WALES, Pa. (PRWEB) May 29, 2018
Teva Pharmaceuticals USA, Inc. (NYSE: TEVA) announced the launch of Life Effects (url: lifeeffects.teva), a new patient-centric website, at the International Alliance of Patients' Organizations (IAPO) 8th Global Patients Congress held on May 23-26, 2018, in Miami.
Developed in collaboration with patients, Life Effects consists of articles, videos and podcasts that offer information, insight and inspiration for people living with one or more chronic conditions. It focuses on the impact a chronic condition has on a patient’s day-to-day life.
“Teva touches the lives of millions of people across the globe on a daily basis. Life Effects is another way in which we demonstrate how we are aligning to meet the evolving needs and expectations of chronically ill patients around the country,” said Brendan O’Grady, Teva’s Executive Vice President and Head of North America Commercial.
Teva created Life Effects after speaking to more than 13,500 patients globally. “We learned that while physicians and other healthcare professionals were patients’ go-to experts when it came to diagnosing a condition and exploring treatment options, there wasn’t a central resource that patients could access on a daily basis when it came to living with a chronic condition,” said Iris Beck-Codner, Teva’s Executive Vice President for Global Brand and Corporate Communications. “We decided to tap into the knowledge and experience of patients themselves to help bridge the information gap.”
“When you’re first diagnosed, no one tells you how your illness is going to affect the non-medical aspects of your life,” said René Brooks, a contributor to Life Effects. “My condition has affected my relationships, my career and my social life…and I wish I knew then what I know now.”
By working with a core group of patients on an ongoing basis, the Life Effects team gets a first-hand, credible perspective on what it’s really like to live with a chronic condition. Together, they tell authentic stories, take a patient-centric look at recent thinking, and offer tips and technologies to help make things a little easier.
The Life Effects team also works with Healthline, the fastest-growing consumer health information site, and Panoply, a premium podcast network which is part of The Slate Group. Healthline and Panoply help Teva integrate the authentic voice and credible point of view of the patient with the rigorous editorial focus of the professional journalist.
At launch, Life Effects will target U.S. patients and focus on four conditions: Attention deficit hyperactivity disorder (ADHD), asthma, depression and migraine. The U.S. launch of Life Effects will be followed by a rollout in Europe later in 2018 that will include an expanded list of conditions.
“We are delighted that Teva accepted our invitation to introduce Life Effects at our global congress. It is a natural fit to this year’s theme of ‘Globally Empowered Patients: Building the Momentum,’ and provides a robust platform for having a dialogue around ways pharma companies, patient groups and others can promote partner-centered healthcare,” said Kawaldip Sehmi, Chief Executive Officer of IAPO.
Earlier this year, Teva announced a new brand positioning—Teva is committed to providing innovative and high-quality medicines to enable people around the world to live better days—and a visual identity, including a new logo. The brand unifies Teva’s businesses around the world after decades of acquisitions and incorporates the company’s untold story on how it impacts the lives of millions of people globally every day. In addition to the U.S., Teva has rolled out the new brand in Canada, France, Russia and Argentina over the past year. Launches in additional markets are planned throughout 2018.
“The new brand is integral to making our mission of bringing valuable medicines to patients easier to execute,” said Beck-Codner. “Life Effects underscores our fresh, updated approach to being more than the world’s largest medicine cabinet. It also demonstrates, in a tangible way, how we are evolving our proposition based on consumer and patient insights and putting patients at the heart of what we do each and every day.”
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions used by millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva’s net revenues in 2017 were $22.4 billion. For more information, visit http://www.tevapharm.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: